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Mutations in ATP2A2 in Patients with Darier’s Disease
To the Editor:
The protein encoded by the ATP2A2, the gene that is mutant
in Darier’s disease (DD) (Jacobsen et al, 1999; Ruiz-Perez et al,
1999; Sakuntabhai et al, 1999a, b, 2000; Ringpfeil et al, 2001;
Takahashi et al, 2001; Yang et al, 2001; Chao et al, 2002), normally
pumps Ca2þ from the cytoplasm to the endoplasmic (or, in mus-
cle, the sarcoplasmic) reticulum.We report additional 23 muta-
tions in the ATP2A2 gene bringing the total reported mutations
to 140.
With the identi¢cation of the ATP2A2 mutation as the ab-
normality underlying DD, the detailed analysis of mutations
may allow increased phenotype^genotype correlation and also a
better understanding of the mechanism by which this protein
moves calcium from the cytoplasm to the endoplasmic reticulum.
In this study, we screened a total of 46 unrelated DD patients: 36
from the USA and 10 from Japan. Sixteen of those were familial
cases and the remaining 30 were sporadic cases. In this cohort of
patients, we identi¢ed 23 distinct ATP2A mutations in 22 unre-
lated families and sporadic cases, whereas no mutations could
be detected in the remaining 24 families and cases. Sixteen
of 23 mutations are predicted to encode single amino acid
substitutions.
DNAwas extracted from peripheral blood leukocytes from the
patients and all available familial members; exons and £anking
intronic DNAwere ampli¢ed by polymerase chain reaction using
published primers (Sakuntabhai et al, 1999a), and the amplicons
were screened by conformation sensitive gel electrophoresis
(CSGE) (Christiano et al, 1997; Hu et al, 2000). Amplicons with
abnormal CSGE patterns were directly sequenced using the
ABI PRISM 310 genetic analyzer (Applied Biosystems, Foster
City, CA). The following sequences were used to identify muta-
tions: ATP2A2a: M23115 and P16614; ATP2A2b: M23114 and
P16615.
We identi¢ed 23 mutations of ATP2A2 in 22 patients by
CSGE analysis and sequencing of DNA from 46 isolated or fa-
milial cases of DD. Of the 23 mutations, 16 are predicted to cause
amino acid substitutions, four to cause premature chain termina-
tion, one to cause a stop codon, one to cause an amino acid dele-
tion, and one to cause an amino acid insertion (Table I).Ten of 16
missense mutations were novel mutations (M1T, R131L, K650E,
P680L, N705K, R750Q, N795S, A805E, E917K, M1023I). The
non-sense mutation of S495Xwas novel. Four of six deletion/in-
sertion mutations were also found to be novel (2198delTC,
3053insAG, 493delC, 185insH). DNA from at least 70 normal con-
trol subjects (50 of US-European ancestry and 20 of Japanese an-
cestry) was screened to con¢rm that each of the 16 predicted
amino acid substitutions was not a simple polymorphism, and
DNAwas screened from all available family members to con¢rm
that the identi¢ed mutations segregated with the clinical disease.
The mutation detection rate in CSGE screening in our cohort
was approximately 50%, which is less than the maximum detect-
ability in CSGE analysis of 70 to 85%.We do not have an exact
explanation for this ¢ndingit might be related to characteristics
of the DNA or possibly due to technical reasons. The clinical
¢ndings in the one family with hemorrhagic DD, four samples
collected in the US, have been described previously (Foresman
et al, 1993), and unlike the mutations in previously reported
DD patients with this unusual phenotype (Ruiz-Perez et al, 1999)
their mutation is predicted to encode a protein with a premature
truncation rather than an amino acid substitution. Our ¢nding
of two mutations in exon 20b is consistent with the reported
presence of this alternatively spliced SERCA2 as the predominant
isoform (both by mRNA and protein assessment) in cultured
keratinocytes and in immunohistologic staining of sections of
intact human epidermis. It is also interesting that seven samples
collected in the US carry two distinct heterozygous missense
mutations. These mutations were supposed to occur on the
same allele, or one of these mutations was supposed to not
alter the function of the molecule, because there has been re-
ported no autosomal recessive DD, and because the ATP2A2
homozygous knockout is embryonic lethal in mice (Periasamy et
al, 1999).
Our identi¢cation of ATP2A2 mutations in this study brings
the number of mutations reported in DD to 140. Of these, 77
are predicted to encode single amino acid substitutions, and
some clustering of these missense mutations is now apparent
(Table II) (Jacobsen et al, 1999; Ruiz-Perez et al, 1999; Sakuntabhai
et al, 1999a, b, 2000; Ringpfeil et al, 2001; Takahashi et al, 2001;
Yang et al, 2001; Chao et al, 2002).
The ¢rst site of clustering is in codon 1, a mutation that pre-
sumably inhibits translation rather than a¡ecting protein function
by base pair substitution. The identi¢cation of three such mu-
tations of the total 77 single base pair substitutions (3.8%) is
proportionately higher than the 107 (0.7%) in an initiating
methionine of a total of 15,776 single base pair substitutions cata-
logued in the Human Gene Mutation Database (P. Stenson, per-
sonal communication, 2001) and probably is further evidence
(beyond the identi¢cation of mutations predicted to have
premature truncating e¡ects) for the pathogenetic e¡ects of hap-
loinsu⁄ciency in this gene. The clusterings at codons 675 to 683
and 765 to 769 are of more cryptic pathogenetic mechanistic sig-
ni¢cance, but suggest regions worthy of more intensive struc-
ture^function analyses.
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Table I. Mutations of ATP2A2 in the patients with Darier’s disease collected in USA (US) and Japan (J)
Patient name Location Mutation Nucleotide change Consequence # of the family member
US-1 exon5 R131L 392G toT missense sporadic
US-2 exon19 2843 del AT CTATGT-CTGT PTCþ 32aa 6af, 6un
US-3 exon15 2198delTC GGTCCT-GGCT PTCþ 3aa 6af, 12un
US-4 exon20b 3053insAG TTTG-TTAGTG PTCþ 5aa 24af, 7un
US-5 exon20b M1023 3069G toT missense sporadic
US-6 exon1 32delAGG GGAGGTG-GGTG 11del E sporadic
US-7 exon14 K650E 1948A to G missense sporadic
exon19 E917K 2749G to A missense sporadic
US-8 exon15 S765L 2294C toT missense sporadic
US-9 exon1 G23E 68G to A missense sporadic
US-10 exon12 S495X 1484C to A nonsense 8af, 1un
US-11 exon8 T357K 1070C to A missense sporadic
US-12 exon15 R750Q 2249G to A missense 14af, 5un
US-13 exon1 M1V 1A to G missense sporadic
US-14 exon16 A805E 2414C to A missense sporadic
US-15 exon1 M1T 2T to C missense 7af, 8un
US-16 exon5 439 del C TTCCTG-TTCTG PTCþ 4aa 2af, 2 un
US-17 exon15 N705K 2115C to A missense sporadic
US-18 exon16 N795S 2384A to G missense sporadic
J-1 exon7 E183K 547 C to A missense sporadic
J-2 exon14 P680L 2039 CtoT missense sporadic
J-3 exon7 E183V 548 A toT missense sporadic
J-4 exon7 553insCAT ctgt-ctCATgt 185insH sporadic
PTC þ n aa indicates a premature termination codon at n amino acids downstream of the mutation.
af: a¡ected, un: una¡ected.
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Table II. Amino acid substitution mutations of ATP2A2 in
Darier’s disease
Location Mutation
Number of times
reported/Citation
Exon 1 (118bp) M1T 1 1
M1V 2 1,4
G23E 2 2,5
N39T 1 2
N39D 1 3
Exon 3 (83bp) L65S 1 4
Exon 5 (139bp) R131L 1 1
R131Q 3 3,6, 10
D149N 1 9
Exon 6 (81bp) P160L 2 3,6
Exon 7 (86bp) E183V 2 1
S186P 1 6
Exon 8 (465bp) G211D 1 4
V223M 1 4
C268F 1 2
I274V 1 8
G310V 1 2
C318R 1 6
L321F 1 8
C344Y 1 3
I348T 2 3,4
T357K 2 1,5
Exon 10 (103bp) E412G 1 6
Exon 12 (123bp) F487S 1 3
Exon 13 (219bp) C560R 2 2
Exon 14 (36bp) K650E 1 1
F675S 1 4
P680L 2 1, 10
K683E 3 2,3
K683R 1 3
Exon 15 (221bp) D702N 1 6
G703S 110
N705K 1 1
M719I 1 8
A745D 1 6
G749R 1 5
R750Q 1 1
S765L 2 1,2
N767S 4 4,2
G769R 2 4,7
Exon 16 (203bp) N795S 1 1
A803T 2 2,6
A805E 1 1
G807R 110
N809I 1 3
A838P 2 4
Exon 17 (86bp) V843F 3 2,4
Exon 18 (134bp) C875G 1 4
Exon 19 (118bp) S916Y 1 9
E917K 1 1
S920Y 2 2,6
H943R 1 4
Exon 20 (267bp) P975R 1 4
M1023I 1 1
Superscript Legend: 1¼Ikeda et al; 2¼ Jacobsen et al, 1999; 3¼Ringpfeil et al,
2001; 4¼Ruiz-Perez et al, 1999; 5¼ Sakuntabhai et al, 1999a; 6¼ Sakuntabhai et
al, 1999b; 7¼ Sakuntabhai et al, 2000; 8¼Takahashi et al, 2001; 9¼Yang et al,
2001; 10¼Chao et al, 2002.
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